FibroGen, Inc.: Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration

Company is on track to file the Phase 3 protocol in the fourth quarter of 2025 SAN FRANCISCO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Office of Orphan ...

Abpro Corporation: Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers

P72, a HER2 × CD3 T cell engager, with preclinical studies demonstrating enhanced HER2-high tumor selectivity and a favorable safety profile ABP-102/CT-P72 represents Abpro's ...

Kyverna Therapeutics, Inc.: Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome

Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in 1H 2026 Miv-cel ...

Quipt Home Medical Corp.: Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's ...

Vanda Pharmaceuticals Inc.: Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) ...

Wesco International: Wesco Partners With Liberty Latin America to Provide Relief to Jamaican Communities Affected by Hurricane Melissa

PITTSBURGH, PA / ACCESS Newswire / December 15, 2025 / Wesco International (NYSE:WCC), a leading provider of business-to-business distribution, logistics services and supply chain solutions, in a join ...

Flagship Communities Real Estate Investment Trust Announces December 2025 Cash Distribution

Not for distribution to U.S. newswire services or dissemination in the United States TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Flagship Communities Real Estate Investment Trust ("Flagship" or the "RE ...

Oryzon Genomics, S.A.: ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting

All resolutions were approved MADRID and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...

Partners Group: Partners Group's announcement of AuM as of 31 December 2025

Annual Results Partners Group's announcement of AuM as of 31 December 2025 15.12.2025 / 15:00 CET/CEST Wednesday, 14 January 2026 6:15pm ...

AllianceBernstein Launches AB US Equity ETF (XCHG) on the New York Stock Exchange

AllianceBernstein Holding L.P. (NYSE: AB) and AllianceBernstein L.P. ("AB"), a leading global investment management ...

Highway Holdings Limited: Highway Holdings Reports Second Quarter Fiscal Year 2026 Results

Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today reported results for the second quarter ...

Adecoagro S.A.: Adecoagro Completes The Acquisition of Profertil

Adecoagro S.A. (NYSE: AGRO) ("Adecoagro" or the "Company"), a leading sustainable production company in South America announces ...